Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
603233.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
+12%
0.38
vs 0.34
Q3.23
N/A
0.22
vs 0.22
Q4.23
N/A
-0.01
vs 0.52
Q1.24
-20%
0.35
vs 0.44
Q2.24
-39%
0.23
vs 0.38
Q3.24
-23%
0.17
vs 0.22
Q4.24
+5889%
0.4
vs -0.01
Q1.25
+14%
0.4
vs 0.35
Q2.25
+0%
0.23
vs 0.23
Q3.25
+13%
0.19
vs 0.17
Sales Growth
YoY
Current
Estimates
Q2.23
+20%
6B vs 5B
Q3.23
+12%
5.7B vs 5.1B
Q4.23
+5%
6.8B vs 6.4B
Q1.24
+13%
6.7B vs 5.9B
Q2.24
+9%
6.6B vs 6B
Q3.24
+11%
6.4B vs 5.7B
Q4.24
0%
6.8B vs 6.8B
Q1.25
+3%
7B vs 6.7B
Q2.25
+10%
7.2B vs 6.6B
Q3.25
+12%
7.1B vs 6.4B
Return on Equity
QoQ
Q2.23
+6%
0.06
vs 0.07
Q3.23
+4%
0.04
vs 0.06
Q4.23
0%
-0.00
vs 0.04
Q1.24
+5%
0.05
vs -0.00
Q2.24
+4%
0.04
vs 0.05
Q3.24
+3%
0.03
vs 0.04
Q4.24
+1%
0.01
vs 0.03
Q1.25
+6%
0.06
vs 0.01
Institutionnal Ownership
Forecast
368%2026-Revenue
194%2026-EPS
508%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. The company was founded in 1999 and is based in Guangzhou, China.
SHH
-0.31Â ( -1.79%)
Relative Strenght
Volume Buzz
-26%
Earning Acce
No
Dist 52w H.
11%Quote Panel
Key Metrics
Relative Strength
603233.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 603233.SS compares to sector?